0001817048-22-000001.txt : 20220218 0001817048-22-000001.hdr.sgml : 20220218 20220218121836 ACCESSION NUMBER: 0001817048-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220218 DATE AS OF CHANGE: 20220218 EFFECTIVENESS DATE: 20220218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gilgamesh Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001817048 IRS NUMBER: 842552195 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-434194 FILM NUMBER: 22651724 BUSINESS ADDRESS: STREET 1: 201 DAM TRAIL #1349 CITY: LINVILLE STATE: NC ZIP: 28646 BUSINESS PHONE: 347-967-6831 MAIL ADDRESS: STREET 1: 201 DAM TRAIL #1349 CITY: LINVILLE STATE: NC ZIP: 28646 D 1 primary_doc.xml X0708 D LIVE 0001817048 Gilgamesh Pharmaceuticals, Inc. 113 University Place Suite 1019 New York NY NEW YORK 10003 3479676831 DELAWARE None None Corporation true 2019 Jonathan Sporn 113 University Place Suite 1019 New York NY NEW YORK 10003 Executive Officer Director Andrew Kruegel 113 University Place Suite 1019 New York NY NEW YORK 10003 Executive Officer Director Robert Berman 113 University Place Suite 1019 New York NY NEW YORK 10003 Director Amy Kruse 113 University Place Suite 1019 New York NY NEW YORK 10003 Director Phil Skolnick 113 University Place Suite 1019 New York NY NEW YORK 10003 Director Pharmaceuticals Decline to Disclose 06b false 2022-02-04 false true false 951 951 0 951 false 1 0 0 0 false Gilgamesh Pharmaceuticals, Inc. John Fallone /s/ John Fallone Attorney for Issuer 2022-02-18